Agarwal Arjun sold ORKA
October 12, 2026 · Form 4 insider transaction
Agarwal Arjun sold 2,100 shares of Oruka Therapeutics, Inc. at $80.76 per share, a transaction worth $169.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,100
Price
$80.76
Total value
$169.6K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 12, 2026
Filing dateOctober 13, 2026
Shares owned after16,377
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.56 to $81.53, inclusive.